Cargando…
Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
OBJECTIVE: Liver biopsy is the most accurate method for determining stage and grade of injury in non-alcoholic fatty liver disease (NAFLD). Given risks and limitations of biopsy, non-invasive tests such as NAFLD fibrosis score, aspartate transaminase (AST) to platelet ratio index, Fib-4, AST/alanine...
Autores principales: | De Silva, Sampath, Li, Wenhao, Kemos, Polychronis, Brindley, James H, Mecci, Jibran, Samsuddin, Salma, Chin-Aleong, Joanne, Feakins, Roger M, Foster, Graham R, Syn, Wing-Kin, Alazawi, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868450/ https://www.ncbi.nlm.nih.gov/pubmed/29588839 http://dx.doi.org/10.1136/flgastro-2017-100865 |
Ejemplares similares
-
Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease
por: Alazawi, William, et al.
Publicado: (2017) -
Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant/advanced fibrosis in patients with nonalcoholic fatty liver disease
por: Hou, Wei, et al.
Publicado: (2020) -
Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease
por: Waller, Kathryn Jane, et al.
Publicado: (2023) -
Network and satellite arrangements in liver disease
por: O'Grady, John G
Publicado: (2013) -
Medical liver biopsy: background, indications, procedure and histopathology
por: Boyd, Alexander, et al.
Publicado: (2019)